While the majority of cases of TAM resolve without sequlae as the GATA1 mutation is lost, ∼10 % of children harbour residual GATA1-mutant cells which then, in the third step, acquire transforming mutations in additional oncogenes leading to ML-DS. This evidence concerns the gene GATA1 and Dravet syndrome.